Pfizer, Moderna stocks fall after RFK Jr. chosen for HHS Secretary
The stocks all fell by more than 5% at the end of the day, except for Pfizer's stock, which only fell 2%, and stocks of the British vaccine creator GSK, which also fell 2%. Novavax was hit the hardest with its shares falling more than 7%.
Shares of vaccine makers fell as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, ...
With the help of TBWA\Chiat\Day New York, pharma giant Moderna is demystifying mRNA science for the average consumer. This ...
Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F.
Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...
Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...
German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing COVID-19 uptake and price levels, ...
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
RESEARCHERS from SINTEF have developed a “simpler” low-cost carbon capture and storage (CCS) system for sequestering ...
Despite the potential in oncology, BNTX's current valuation is high relative to its non-COVID revenue prospects, warranting a ...
Although it is seeing a downturn in sales and profits, German biotech BioNTech (Nasdaq: BNTX) is continuing to acquire ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback